Low CLL-1 Expression Is a Novel Adverse Predictor in 123 Patients with De Novo CD34+ Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Low CLL-1 Expression Is a Novel Adverse Predictor in 123 Patients with De Novo CD34+ Acute Myeloid Leukemia

Published:2017-10-15 Issue:20 Volume:26 Page:1460-1467
ISSN:1547-3287
Container-title:Stem Cells and Development
language:en
Short-container-title:Stem Cells and Development

Author:

Wang Yan-Yu¹²³,Chen Wen-Lian⁴,Weng Xiang-Qin¹,Sheng Yan¹,Wu Jing¹,Hao Jie²,Liu Zhan-Yun²,Zhu Yong-Mei¹,Chen Bing¹,Xiong Shu-Min¹,Chen Yu¹,Chen Qiu-Sheng¹,Sun Hui-Ping¹,Li Jun-Min¹,Wang Jin¹

Affiliation:

1. State Key Laboratory of Medical Genomics, Department of Hematology, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

2. Department of Hematology, Bei Zhan Hospital, Shanghai, China.

3. Department of Hematology, The Central Hospital of Xu Hui District, Shanghai, China.

4. University of Hawaii Cancer Center, Honolulu, Hawaii.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Developmental Biology,Hematology

Link

https://www.liebertpub.com/doi/pdf/10.1089/scd.2016.0310

Reference31 articles.

1. The AML Salad Bowl

2. Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia